Literature DB >> 11788372

Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content.

Susanne Neschen1, Irene Moore, Werner Regittnig, Chun Li Yu, Yanlin Wang, Marc Pypaert, Kitt Falk Petersen, Gerald I Shulman.   

Abstract

To examine the mechanism by which fish oil protects against fat-induced insulin resistance, we studied the effects of control, fish oil, and safflower oil diets on peroxisomal content, fatty acyl-CoA, diacylglycerol, and ceramide content in rat liver and muscle. We found that, in contrast to control and safflower oil-fed rats, fish oil feeding induced a 150% increase in the abundance of peroxisomal acyl-CoA oxidase and 3-ketoacyl-CoA thiolase in liver but lacked similar effects in muscle. This was paralleled by an almost twofold increase in hepatic peroxisome content (both P < 0.002 vs. control and safflower). These changes in the fish oil-fed rats were associated with a more than twofold lower hepatic triglyceride/diacylglycerol, as well as intramuscular triglyceride/fatty acyl-CoA, content. In conclusion, these data strongly support the hypothesis that n-3 fatty acids protect against fat-induced insulin resistance by serving as peroxisome proliferator-activated receptor-alpha ligands and thereby induce hepatic, but not intramuscular, peroxisome proliferation. In turn, an increased hepatic beta-oxidative capacity results in lower hepatic triglyceride/diacylglycerol and intramyocellular triglyceride/fatty acyl-CoA content.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788372      PMCID: PMC2995503          DOI: 10.1152/ajpendo.00414.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  19 in total

1.  Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.

Authors:  J K Kim; O Gavrilova; Y Chen; M L Reitman; G I Shulman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

2.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 3.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 4.  Compartmentalization of ceramide signaling: physical foundations and biological effects.

Authors:  R N Kolesnick; F M Goñi; A Alonso
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

5.  Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.

Authors:  J M Ye; P J Doyle; M A Iglesias; D G Watson; G J Cooney; E W Kraegen
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

6.  Cytochemical detection of catalase with 3,3'-diaminobenzidine. A quantitative reinvestigation of the optimal conditions.

Authors:  M LeHir; V Herzog; H D Fahimi
Journal:  Histochemistry       Date:  1979-11

Review 7.  The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.

Authors:  E W Kraegen; G J Cooney; J M Ye; A L Thompson; S M Furler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

8.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.

Authors:  J K Kim; J J Fillmore; Y Chen; C Yu; I K Moore; M Pypaert; E P Lutz; Y Kako; W Velez-Carrasco; I J Goldberg; J L Breslow; G I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 9.  Triglycerides, fatty acids and insulin resistance--hyperinsulinemia.

Authors:  E W Kraegen; G J Cooney; J Ye; A L Thompson
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

10.  Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability.

Authors:  K N Frayn; P F Maycock
Journal:  J Lipid Res       Date:  1980-01       Impact factor: 5.922

View more
  40 in total

1.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity.

Authors:  Sjoerd Aa van den Berg; Bruno Guigas; Silvia Bijland; Margriet Ouwens; Peter J Voshol; Rune R Frants; Louis M Havekes; Johannes A Romijn; Ko Willems van Dijk
Journal:  Nutr Metab (Lond)       Date:  2010-03-27       Impact factor: 4.169

3.  Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults.

Authors:  Gordon I Smith; Sophie Julliand; Dominic N Reeds; David R Sinacore; Samuel Klein; Bettina Mittendorfer
Journal:  Am J Clin Nutr       Date:  2015-05-20       Impact factor: 7.045

4.  Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.

Authors:  Fatima Kasbi-Chadli; Véronique Ferchaud-Roucher; Michel Krempf; Khadija Ouguerram
Journal:  Eur J Nutr       Date:  2015-03-19       Impact factor: 5.614

5.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

Authors:  Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 6.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

7.  Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice.

Authors:  Phillip J White; Makoto Arita; Ryo Taguchi; Jing X Kang; André Marette
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

8.  MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice.

Authors:  Rachel J Roth; Annie M Le; Lei Zhang; Mario Kahn; Varman T Samuel; Gerald I Shulman; Anton M Bennett
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

9.  Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity.

Authors:  Cheol Soo Choi; David B Savage; Lutfi Abu-Elheiga; Zhen-Xiang Liu; Sheene Kim; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Richard M Reznick; Roberto Codella; Dongyan Zhang; Gary W Cline; Salih J Wakil; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-08       Impact factor: 11.205

10.  Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.

Authors:  David B Savage; Cheol Soo Choi; Varman T Samuel; Zhen-Xiang Liu; Dongyan Zhang; Amy Wang; Xian-Man Zhang; Gary W Cline; Xing Xian Yu; John G Geisler; Sanjay Bhanot; Brett P Monia; Gerald I Shulman
Journal:  J Clin Invest       Date:  2006-02-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.